Patrick Kim Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Combination of HDAC and mitochondrial-targeted metabolism inhibitors exhibits strong therapeutic synergy in vitro and in vivo against neuroblastoma — Poster Session 2 with wine & cheese